sec digital currency People also ask

As of the close of early trading, the Nikkei 225 index fell by 1.2% and the Dongzheng index fell by 1.3%.Clown won the TGA Best Indie Game Award.The General Administration of Market Supervision launched a pilot program to deepen credit repair. The gold T+D of Shanghai Gold Exchange fell by 1.01% to 617.82 yuan/gram at the beginning of trading on Friday, December 13th. Silver T+D of Shanghai Gold Exchange fell 1.27% to 7722.0 yuan/kg at the beginning of trading on Friday, December 13th.

The concept of robot bottomed out and Tianqi shares rose linearly, and Tianqi shares rose linearly. Before that, the construction industry went out of 9 boards in 10 days, Astar went out of 13 boards in 21 days, and Tongda Power went up. Hanyu Group, Maihe, Jiangsu Reilly, Hanwei Technology and Best were among the top gainers. The Public Offering of Fund sales qualification of Goldman Sachs (China) Securities was approved, and the Beijing Securities Regulatory Bureau approved the sales qualification of Goldman Sachs (China) Securities Co., Ltd. to publicly raise securities investment funds. According to the reply, the sales license of Goldman Sachs (China) Securities Public Offering Securities Investment Fund is valid for 3 years from the date of first issuance. Goldman Sachs (China) Securities shall, in accordance with the requirements of the Securities Investment Fund Law, the Measures for the Supervision and Administration of Sales Organizations of Public Offering Securities Investment Funds and other relevant laws and regulations, complete the preparatory work for opening within 6 months.

Malaysia Airlines and Uzbekistan Airlines resumed code sharing agreement.SHIBOR reported 1.4040% overnight, down by 7.80 basis points. In 7 days, SHIBOR reported 1.7580%, up 12.30 basis points. SHIBOR reported 1.7350% in three months, down by 0.50 basis point.Ha Sanlian: Four kinds of drugs are planned to win the bid for national centralized procurement. Ha Sanlian announced that the company and its wholly-owned subsidiary Lanxi Pharmaceutical participated in the tenth batch of national centralized procurement of drugs organized by the state. The company's esmolol hydrochloride injection, pentoxifylline injection, potassium chloride injection, and tandospirone citrate tablets of Lanxi Pharmaceutical intend to win the bid for this centralized procurement. If the subsequent purchase contract is signed and implemented, it will help to expand the sales of related products and improve the market share and brand influence. The prices of the above-mentioned drugs are respectively 1.34 yuan for esmolol hydrochloride injection, 0.59 yuan for pentoxifylline injection, 0.16 yuan for potassium chloride injection and 6.56 yuan for tandospirone citrate tablets.